TrialBMC cancer2026

Platinum-free triplet therapy with nab-paclitaxel, S-1, and tislelizumab as first-line treatment for advanced gastric/gastroesophageal junction adenocarcinoma: a phase ii single-arm trial.

Yuejun Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.